Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Product
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Product outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Blood Screening Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.2. Market restraint analysis
3.5. Blood Screening Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
Chapter 4. Blood Screening Market: Technology Estimates & Trend Analysis
4.1. Blood Screening Market: Key Takeaways
4.2. Blood Screening Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Nucleic Acid Amplification (NAT)
4.3.1. Nucleic acid amplification (NAT) market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. ELISA
4.4.1. ELISA market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
4.5.1. Chemiluminescence immunoassay (CLIA) and enzyme immunoassay (EIA) market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Next-Generation Sequencing
4.6.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Western Blotting
4.7.1. Western blotting market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Blood Screening Market: Product Estimates & Trend Analysis
5.1. Blood Screening Market: Key Takeaways
5.2. Blood Screening Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Reagent
5.3.1. Reagent market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Instrument
5.4.1. Instrument market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Blood Screening Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Blood Screening Market by Region: Key Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Abbott
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Danaher Corporation (Beckman Coulter)
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Bio-Rad Laboratories, Inc.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Hoffman-La Roche Ltd.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Grifols, S.A.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Ortho-Clinical Diagnostics, Inc.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Siemens Healthcare GmbH
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Thermo Fisher Scientific, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. SOFINA s.a (Biomerieux)
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
Table 1 List of abbreviation
Table 2 North America blood screening market, by technology, 2018 - 2030 (USD Million)
Table 3 North America blood screening market, by product, 2018 - 2030 (USD Million)
Table 4 North America blood screening market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. blood screening market, by technology, 2018 - 2030 (USD Million)
Table 6 U.S. blood screening market, by product, 2018 - 2030 (USD Million)
Table 7 Canada blood screening market, by technology, 2018 - 2030 (USD Million)
Table 8 Canada blood screening market, by product, 2018 - 2030 (USD Million)
Table 9 Europe blood screening market, by technology, 2018 - 2030 (USD Million)
Table 10 Europe blood screening market, by product, 2018 - 2030 (USD Million)
Table 11 Europe blood screening market, by region, 2018 - 2030 (USD Million)
Table 12 Germany blood screening market, by technology, 2018 - 2030 (USD Million)
Table 13 Germany blood screening market, by product, 2018 - 2030 (USD Million)
Table 14 UK blood screening market, by technology, 2018 - 2030 (USD Million)
Table 15 UK blood screening market, by product, 2018 - 2030 (USD Million)
Table 16 France blood screening market, by technology, 2018 - 2030 (USD Million)
Table 17 France blood screening market, by product, 2018 - 2030 (USD Million)
Table 18 Italy blood screening market, by technology, 2018 - 2030 (USD Million)
Table 19 Italy blood screening market, by product, 2018 - 2030 (USD Million)
Table 20 Spain blood screening market, by technology, 2018 - 2030 (USD Million)
Table 21 Spain blood screening market, by product, 2018 - 2030 (USD Million)
Table 22 Sweden blood screening market, by technology, 2018 - 2030 (USD Million)
Table 23 Sweden blood screening market, by product, 2018 - 2030 (USD Million)
Table 24 Norway blood screening market, by technology, 2018 - 2030 (USD Million)
Table 25 Norway blood screening market, by product, 2018 - 2030 (USD Million)
Table 26 Denmark blood screening market, by technology, 2018 - 2030 (USD Million)
Table 27 Denmark blood screening market, by product, 2018 - 2030 (USD Million)
Table 28 Asia Pacific blood screening market, by technology, 2018 - 2030 (USD Million)
Table 29 Asia Pacific blood screening market, by product, 2018 - 2030 (USD Million)
Table 30 Asia Pacific blood screening market, by region, 2018 - 2030 (USD Million)
Table 31 Japan blood screening market, by technology, 2018 - 2030 (USD Million)
Table 32 Japan blood screening market, by product, 2018 - 2030 (USD Million)
Table 33 China blood screening market, by technology, 2018 - 2030 (USD Million)
Table 34 China blood screening market, by product, 2018 - 2030 (USD Million)
Table 35 India blood screening market, by technology, 2018 - 2030 (USD Million)
Table 36 India blood screening market, by product, 2018 - 2030 (USD Million)
Table 37 Australia blood screening market, by technology, 2018 - 2030 (USD Million)
Table 38 Australia blood screening market, by product, 2018 - 2030 (USD Million)
Table 39 Thailand blood screening market, by technology, 2018 - 2030 (USD Million)
Table 40 Thailand blood screening market, by product, 2018 - 2030 (USD Million)
Table 41 South Korea blood screening market, by technology, 2018 - 2030 (USD Million)
Table 42 South Korea blood screening market, by product, 2018 - 2030 (USD Million)
Table 43 Latin America blood screening market, by technology, 2018 - 2030 (USD Million)
Table 44 Latin America blood screening market, by product, 2018 - 2030 (USD Million)
Table 45 Latin America blood screening market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil blood screening market, by technology, 2018 - 2030 (USD Million)
Table 47 Brazil blood screening market, by product, 2018 - 2030 (USD Million)
Table 48 Mexico blood screening market, by technology, 2018 - 2030 (USD Million)
Table 49 Mexico blood screening market, by product, 2018 - 2030 (USD Million)
Table 50 Argentina blood screening market, by technology, 2018 - 2030 (USD Million)
Table 51 Argentina blood screening market, by product, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa blood screening market, by technology, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa blood screening market, by product, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa blood screening market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa blood screening market, by technology, 2018 - 2030 (USD Million)
Table 56 South Africa blood screening market, by product, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia blood screening market, by technology, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia blood screening market, by product, 2018 - 2030 (USD Million)
Table 59 UAE blood screening market, by technology, 2018 - 2030 (USD Million)
Table 60 UAE blood screening market, by product, 2018 - 2030 (USD Million)
Table 61 Kuwait blood screening market, by technology, 2018 - 2030 (USD Million)
Table 62 Kuwait blood screening market, by product, 2018 - 2030 (USD Million)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
